Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294)
China flag China · Delayed Price · Currency is CNY
30.48
+0.18 (0.59%)
Jan 3, 2025, 3:04 PM CST

Shenzhen Salubris Pharmaceuticals Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Net Income
610.61580.07637.09533.7360.86715.2
Upgrade
Depreciation & Amortization
346.55346.55320.16304.27246.03229.36
Upgrade
Other Amortization
32.5732.5728.8720.1617.9217.27
Upgrade
Loss (Gain) From Sale of Assets
0.480.480.181.3-0.211.11
Upgrade
Asset Writedown & Restructuring Costs
52.552.550.67131.6284.3112.6
Upgrade
Loss (Gain) From Sale of Investments
-20.21-20.21-44.14-134.2426.7831.2
Upgrade
Provision & Write-off of Bad Debts
2.492.4930.44-8.29-
Upgrade
Other Operating Activities
310.5422.1111.6630.326.9-20.64
Upgrade
Change in Accounts Receivable
3.963.96-89.4269.97613.44356.35
Upgrade
Change in Inventory
51.2351.23-114.11-46.53111.4267.55
Upgrade
Change in Accounts Payable
-219.18-219.1841.69277.5452.29-48.52
Upgrade
Change in Other Net Operating Assets
--104.38--152.93
Upgrade
Operating Cash Flow
1,158839.44970.81,1851,3741,507
Upgrade
Operating Cash Flow Growth
43.69%-13.53%-18.07%-13.78%-8.78%12.38%
Upgrade
Capital Expenditures
-597.18-671-598.96-482.5-642.47-457.19
Upgrade
Sale of Property, Plant & Equipment
0.590.580.591.590.890.15
Upgrade
Investment in Securities
-1,238-730.75-682.0693.53-225.04222.93
Upgrade
Other Investing Activities
45.7330.357.1217.7317.1721.81
Upgrade
Investing Cash Flow
-1,789-1,371-1,273-369.65-849.44-212.31
Upgrade
Short-Term Debt Issued
-223.73596.83303.9--
Upgrade
Long-Term Debt Issued
----332124
Upgrade
Total Debt Issued
59.66223.73596.83303.9332124
Upgrade
Short-Term Debt Repaid
--358.63-183.6-639.52--
Upgrade
Long-Term Debt Repaid
--16.67-10.82-13.36-277.72-37.7
Upgrade
Total Debt Repaid
-204.6-375.3-194.42-652.87-277.72-37.7
Upgrade
Net Debt Issued (Repaid)
-144.94-151.56402.41-348.9754.2886.3
Upgrade
Issuance of Common Stock
---2,331--
Upgrade
Repurchase of Common Stock
---274.31-327.86-284.94-
Upgrade
Common Dividends Paid
-546.04-549.37-441.2-15.54-534.82-852.75
Upgrade
Other Financing Activities
598.11-4.57-88.41-90.45-1.38-63.13
Upgrade
Financing Cash Flow
-92.87-705.5-401.51,548-766.86-829.59
Upgrade
Foreign Exchange Rate Adjustments
-10.384.0732.96-6.77-4.842.08
Upgrade
Net Cash Flow
-733.38-1,233-671.042,357-246.81466.83
Upgrade
Free Cash Flow
561.22168.44371.84702.48731.861,049
Upgrade
Free Cash Flow Growth
362.48%-54.70%-47.07%-4.02%-30.26%4.13%
Upgrade
Free Cash Flow Margin
14.35%5.01%10.68%22.97%26.72%23.48%
Upgrade
Free Cash Flow Per Share
0.510.150.340.660.721.00
Upgrade
Cash Income Tax Paid
432.02406.42404.25324.11295.41850.92
Upgrade
Levered Free Cash Flow
214.22-517.28494.8240.9723.091,252
Upgrade
Unlevered Free Cash Flow
224.03-506.42502.64247.48734.071,262
Upgrade
Change in Net Working Capital
-44.96579.5-399.08-90.37-921.15-957.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.